Amgen‘s adjusted net income was $1.28m, compared to $1.33m for the same period in the prior year.
The company has posted adjusted operating income of $1.47m for the second quarter ended 30 June 2011, compared to $1.65m for the same period in 2010.
Adjusted earnings per share (EPS) were $1.37 for the second quarter of 2011, a decrease of 1%, compared to $1.38 for the second quarter of 2010.
Amgen chairman and CEO Kevin Sharer said their products recorded 8% growth during the quarter.